EBS
NYSE · Biotechnology
Emergent Biosolutions Inc
$8.21
+0.20 (+2.50%)
Open$8.12
Previous Close$8.01
Day High$8.45
Day Low$8.12
52W High$14.06
52W Low$4.02
Volume—
Avg Volume748.1K
Market Cap417.79M
P/E Ratio7.94
EPS$0.83
SectorBiotechnology
Analyst Ratings
Strong Buy
6 analysts
Price Target
+229.8% upside
Current
$8.21
$8.21
Target
$27.08
$27.08
$18.81
$27.08 avg
$37.55
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 677.48M | 777.01M | 356.03M |
| Net Income | 47.97M | 49.51M | -80,261,545 |
| Profit Margin | 7.1% | 6.7% | -22.5% |
| EBITDA | 188.95M | 205.88M | -95,339,299 |
| Free Cash Flow | — | — | -67,766,487 |
| Rev Growth | -12.8% | -12.8% | +7.9% |
| Debt/Equity | 1.09 | 1.09 | 0.39 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |